Experts Discuss ADCs for HER2-Negative/Ultralow/Low MBC

Decera Clinical Education Oncology Podcast · Mar 26, 2026 · 19m

In this podcast episode, Aditya Bardia, MD, MPH, FASCO, and Ruta Rao, MD, discuss ADCs for HER2-negative/ultralow/low metastatic breast cancer, including:

Classifying HER2 expression in MBC today (HER2 negative/ultralow/low/positive) and why this is important

ADCs for HER2-negative/ultralow/low MBC

Patient communication: best practices in discussing treatment goals and potential AEs

Presenters:

Aditya Bardia, MD, MPH, FASCO

Professor of Medicine

Geffen School of Medicine

University of California

Los Angeles, California

Ruta Rao, MD​

Medical Director, Rush University Cancer Center

Professor of…